Comparison 20. OnabotulinumtoxinA 30 units versus 10 units one cycle of treatment glabellar lines.
| Outcome or subgroup title | No. of studies | No. of participants | Statistical method | Effect size |
|---|---|---|---|---|
| 20.1 Physician assessment of success by analysing scores and scales | 1 | Risk Ratio (M‐H, Random, 95% CI) | Totals not selected | |
| 20.1.1 4 weeks | 1 | Risk Ratio (M‐H, Random, 95% CI) | Totals not selected | |
| 20.1.2 8 weeks | 1 | Risk Ratio (M‐H, Random, 95% CI) | Totals not selected | |
| 20.1.3 12 weeks | 1 | Risk Ratio (M‐H, Random, 95% CI) | Totals not selected | |
| 20.1.4 16 weeks | 1 | Risk Ratio (M‐H, Random, 95% CI) | Totals not selected | |
| 20.2 Total adverse events | 1 | Risk Ratio (M‐H, Random, 95% CI) | Totals not selected |